Objectives: This analysis estimated alcohol-attributable burden of disease for Switzerland. 12.9 %, women: 4.2 %) were attributable to alcohol. These numbers are net numbers already incorporating the cardioprotective and other benefi cial effects of alcohol.
2004)
). In Europe especially, alcohol consumption and attributable burden of disease is high compared to global averages. In 2002, adult per capita alcohol consumption was estimated to be 11.9 litres (l) pure alcohol in Europe, almost twice the global average of 6.2 l (Rehm et al. 2006a) . In terms of burden of disease, Europe was found to have alcohol-attributable deaths, years of life lost (YLL) and disability adjusted life years (DALYs) that were double or triple those estimated globally (Rehm et al. 2006a) . Within Europe there are regional differences as well: patterns of drinking and burden of disease have a very defi nite West to East gradient, with less detrimental patterns of consumption (such as drinking in moderation and with meals) in Western Europe and more harmful patterns (such as heavy episodic drinking) in Central and Eastern Europe (Popova et al. 2007; Rehm et al. 2007a) . As a result, an increasing gradient of alcohol-attributable disease was also seen for 2002, with rates of deaths, YLLs and DALYs increasing from West to East (Rehm et al. 2006a; Rehm et al. 2007a ). In addition, there are regional patterns that are sex-specifi c (Makela et al. 2006) . In addition to regional trends in alcohol consumption and attributable disease, Europe is heterogeneous at the country level with respect to alcohol consumption and attributable harm. Likewise, the type of alcohol most widely consumed varies from country to country, with a particular increase in beer drinking and a corresponding decrease in wine and spirits consumption in the past decades (WHO Global Alcohol Database: http://www.who.int/globalatlas/default.asp ). Thus, to develop policy recommendations, the World Health Organization (WHO) stressed the importance of efforts to monitor alcohol consumption at the country level and recommend corresponding alcohol policy that serve individual country needs (World Health Assembly 2005) . 
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For all injury categories (shaded areas), the approach assuming that consumption strata specifi c RRs are generalisable across countries was only used as a sensitivity analysis. The main analyses used regionspecifi c alcohol-attributable fractions, based on both the level of consumption and drinking pattern (for derivation see Rehm et al., 2004) . (Rehm et al., 2004) Poisonings a X40-X49 U151 (Rehm et al., 2004) Falls a W00-W19 U152 (Rehm et al., 2004) Drownings a W65-W74 U154 (Rehm et al., 2004) Other unintentional injuries a   Rest of V, W20-W64, W75-W99,  X10-X39, X50-X59, Y40-Y86,  Y88, Y89 U155 (Rehm et al., 2004) Self-infl icted injuries a X60-X84, Y870 U157 (Rehm et al., 2004) Violence a X85-Y09, Y871 U158 (Rehm et al., 2004) Other intentional injuries a Y35 U160 (Rehm et al., 2004) The aim of this project was to model the impact of alcohol on mortality, years of life lost and burden of disease for Switzerland in a way that is compatible with current effort of the WHO in alcohol monitoring and surveillance. (Midanik 1982; Rehm 1998) , results had to be adjusted (for a description of methodology see Rehm et al., in press ). The survey data accounted for 48 % of the per capita consumption. The estimates for this study are based on a combination of both data sources, where the adult per capita consumption is taken as the best indicator of the overall level of consumption (Gmel & Rehm 2004) , and survey information is taken as the best indicator for the distribution of consumption by sex and age. The exact methods are described elsewhere (Rehm et al. 2006a; Rehm et al. 2006b; 2007b) . Relating alcohol exposure to disease and injury outcomes Alcohol consumption was found to be causally related to a number of diseases, both chronic and acute, as well as a number of injury categories. The disease categories were taken from the GBD study (for GBD categories: Mathers et al. 2001 ; for the relationship to alcohol: Rehm et al. 2003c; Rehm et al. 2004) and are listed in Table 1 .
Methods

Data indicating burden of disease
RR -relative risk a AAFs are taken from CRA for non-A regions (based on pooled cross-sectional time-series analyses) b V01-V04, V06, V09-V80, V87, V89, V99. If four-digit ICD-10 data are available, use: V01.1-V01.9, V02.1-V02.9, V03.1-V03.9, V04.1-V04.9, V06.1-V06.9, V09.2, V09.3, V10.4-V10.9, V11.4-V11.9, V12.3-V12.9, V13.3-V13.9, V14.3-V14.9, V15.4-V15.9, V16.4-V16.9, V17.4-V17.9, V18.4-V18.9, V19.4-V19.6, V20.3-V20.9, V21.3-V21.9, V22.3-V22.9, V23.3-V23.9, V24.3-V24.9, V25.3-V25.9, V26.3-V26.9, V27.3-V27.9, V28.3-V28.9, V29.4-V29.9, V30.4.V30.9, V31.4-V31.9, V32.4-V32.9, V33.4-V33.9, V34.4-V34.9, V35.4-V35.9, V36.4-V36.9, V37.4-V37.9, V38.4-V38.9, V39.4-V39.9, V40.4-V40.9, V41.4-V41.9, V42.4-V42.9, V43.4-V43.9, V44.4-V44.9, V45.4-V45.9, V46.4-V46.9, V47.4-V47.9, V48.4-V48.9, V49.4-V49.9, V50.4-V50.9, V51.4-V51.9, V52.4-V52.9, V53.4-V53.9, V54.4-V54.9, V55.4-V55.9, V56.4-V56.9, V57.4-V57.9, V58.4-V58.9, V59.4-V59.9, V60.4-V60.9, V61.4-V61.9, V62.4-V62.9, V63.4-V63.9, V64.4-V64.9, V65.4-V65.9, V66.4-V66.9, V67.4-V67.9, V68.4-V68.9, V69.4-V69.9, V70.4-V70.9, V71.4-V71.9, V72.4-V72.9, V73.4-V73.9, V74.4-V74.9, V75.4-V75.9, V76.4-V76.9, V77.4-V77.9, V78.4-V78.9, V79.4-V79.9, V80.3-V80.5, V81.1, V82. 
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Alcohol consumption and alcohol-attributable burden of disease © Birkhäuser Verlag, Basel, 2007 in Switzerland, 2002 To determine the benefi cial and detrimental health conditions causally attributable to alcohol for inclusion in this study, the usual epidemiological criteria were used with specifi c emphasis on the following (Hill 1965; English et al. 1995; Rothman & Greenland 1998) : consistency across several studies, established experimental biological evidence of mediating processes or at least strong physiological plausibility (biological mechanisms), strength of the association (effect size), and temporality (i. e., cause before effect). The disease categories found to be causally related were also cross-validated against major reviews (for a summary: Rehm et al. 2003c ). The fi nal selection was the same as for the Comparative Risk Assessment study (CRA) 2000 (Rehm et al. 2004; WHO 2002 ) with one exception: colorectal cancer was added. In other words, all of the major review studies in the 1990s and the early 2000s concluded a causal relationship between alcohol and the respective disease or injury category selected for this study (Rehm et al. 2003c ), except for colorectal cancer, where some of the evidence is newer (Boffetta et al. 2006; Cho et al. 2004) . In 2007, the International Agency for Research on Cancer (Baan et al. 2007 ) established alcohol consumption to be carcinogenic for colorectal cancer, and thus the decision to include this type of cancer seems justifi ed. The same criteria were used for determining causality with respect to detrimental and benefi cial effects. Care was taken to control for potential confounding, especially confounding by tobacco smoking. Thus, even though alcohol was consistently related to lung cancer, even after usual control for confounding, it was not included as alcohol-attributable, because up to now there is no convincing biological pathway, and because residual confounding by tobacco smoking cannot be excluded. Table 1 gives an overview on relative risks (RR) for different diseases by drinking categories. For most chronic disease categories, alcohol-attributable fractions (AAFs) of disease were derived from combining the prevalence of exposure and relative risk estimates based on meta-analyses (Cho et al. 2004; Corrao et al. 2000; English et al. 1995; Gutjahr et al. 2001; Rehm et al. 2003c; Ridolfo & Stevenson 2001) using the following formula (Walter 1976; 1980) :
Risk relations
Where i: exposure category with baseline exposure or no exposure i = 0 RR(i): relative risk at exposure level i compared to no consumption P(i): prevalence of the i th category of exposure AAFs, as derived from the formula above, can be interpreted as refl ecting the proportion of disease that would disappear if there had been no alcohol consumption. For depression and injuries, AAFs were taken from the CRA study (see Rehm et al. 2004 , for a detailed description of underlying assumptions and calculations). All AAFs by sex and age are available from the fi rst author upon request. Table 3 . Overall, 2432 men and 1033 women died because of alcohol consumption and, taking into consideration the benefi cial effects, 1575 net deaths among men and 441 net deaths among women were attributed to alcohol consumption. In relative terms, alcohol consumption caused almost 4 times as many net deaths in men compared to women, respectively, which was expected given the higher consumption in men. Despite their differences in relative and absolute mortality, however, the top causes of death were the same for both men and women, with the top three being cancer (M: 33.7 % of all alcohol-attributable deaths, W: 39.5 %), cardiovascular diseases (M: 18.7 %, W: 17.7 %), and liver cirrhosis (M: 17.9 %, W: 18.4 %). In addition to causing death, alcohol also prevented death from cardiovascular diseases (mainly ischaemic heart disease) and diabetes mellitus. Cardiovascular mortality prevented totalled 649 for men and 544 for women, which was greater than all deaths caused by alcohol-attributable cardiovascular diseases for each sex in Switzerland. Overall in Switzerland, alcohol prevented roughly one-third of all deaths caused by alcohol in men and about half of all deaths caused in women.
Results
Prevalence of exposure
Comparison with the rest of Western Europe as operationalized by the WHO Europe A region showed some similarities and differences. Among deaths caused by alcohol, Switzerland and Europe A were identical in the top three categories, although the relative importance of alcohol-attributable liver cirrhosis was higher in Europe A, and cardiovascular diseases were relatively more important in Switzerland. Deaths prevented by alcohol, especially for cardiovascular diseases, showed some marked differences. In Europe A, the deaths prevented by alcohol totalled approximately half of all alcohol-attributable deaths for men and outnumbered deaths among women by a factor of 2, resulting in a net preventive effect of alcohol among women in Europe A. In Switzerland, however, there were approximately three times more deaths caused by alcohol than prevented among men, and twice as many among women, accounting for the opposite net effect seen in Swiss women compared to European women (1.4 % of all deaths versus -2.4 %) and the higher relative importance of alcohol as a cause of death in Swiss men compared to the rest of Europe A (5.2 % of all deaths versus 3.5 %).
Years of life lost
Alcohol-attributable YLLs in Switzerland and comparisons with the rest of Europe A are shown in Table 4 . Among Swiss men and women, the top three causes of YLLs were cancer, liver cirrhosis, and unintentional injuries. The shift from cardiovascular diseases to unintentional injuries was due to the fi nding that acute outcomes such as injury categories were associated with younger aged cohorts compared to chronic disease categories more associated with older age groups. Similar trends with respect to YLLs caused and prevented by alcohol were also seen within Switzerland and in comparison to Europe A, with much higher relative YLLs prevented in Europe A among both men and women. This was especially true among women, where a net protective effect was seen in Europe A (-1.2 %) and a marked net detrimental effect was estimated for Switzerland (4.9 %).
Disability adjusted life years
DALYs attributable to alcohol consumption in Switzerland and Europe A are shown in Table 5 . The most striking difference between DALYs and YLLs/deaths was the much higher relative importance of neuropsychiatric disorders with respect to DALYs, especially alcohol use disorders. In Switzerland (and Europe) this disease category accounted for roughly half of all alcohol-attributable DALYs among men (52.5 %) and women (42.1 %). This was due to the fact that alcohol use disorders are much less fatal and occur earlier in life than the more traditional chronic diseases such as heart disease and cancers. The fact that DALYs are a time-based measure becomes important here, i. e. the longer one lives with a disability, the higher the DALYs. In addition, alcohol use and other neuropsychiatric disorders are chronic relapsing diseases with multiple episodes over a lifetime, resulting in high Int J Public Health 52 (2007) 383-392 Alcohol consumption and alcohol-attributable burden of disease © Birkhäuser Verlag, Basel, 2007 in Switzerland, 2002 disability over the life course (Leshner 1999; McLellan et al. 2000) . The majority of the other DALYs caused by alcohol in Switzerland and Europe A consisted of cancer, liver cirrhosis, and unintentional injuries. The protective effect of alcohol was also diminished using DALYs as an outcome measure compared to mortality, accounting for roughly an eighth of DALYs caused in men and a quarter of life years caused in women in Switzerland. The diminished effect on DALYs is trivial, as alcohol use disorders were the main contributor to DALYs and alcohol cannot have a protective effect on alcohol use disorders. In Europe A, this diminished effect was also seen, especially among men, where a ratio of about 8:1 was estimated. Among women, DALYs caused by alcohol outnumbered DALYs prevented by a ratio of about 4:3. Overall, the relative detrimental impact of alcohol was similar in Swiss and European men, but about 3 times greater in Swiss compared to European women.
Discussion
Overall, before we discuss the implications for prevention, we would like to point out some methodological caveats. First, for consistency purposes and lack of alternatives, we took the mortality, YLL and DALY data from the WHO database. Switzerland has not yet conducted a detailed burden of disease study, so these should be seen as approximations that will be updated when the Swiss data become available. Second, the relative risks were derived from meta-analyses and are assumed to be consistent across countries, mainly because they refl ect biological mechanisms. This assumption is probably not problematic for Switzerland, as most studies included in the meta-analyses are from European or North American countries with similar genetic background and health care systems. However, the AAFs for injury may be more problematic, as the relationship between alcohol and injury has been shown to be infl uenced by culture and society Percentage of all deaths attributable to alcohol 5.2 % 1.4 % 3.5 % -2.4 % to a large degree (Sethi et al. 2006) . It is necessary that ongoing and future Swiss studies should be used to put the results of this study in perspective. Third, the estimates for the age group 70 years and older are certainly overestimates, both for benefi cial and detrimental effects. Relative risks have been shown to decrease with age and, while there are quantifi cations of this effect for major tobacco-related risks, no quantification exists for alcohol-attributable diseases (see Rehm et al. (2006c) for references and further information). Fourth, there may be some confounding by smoking which has not been removed by the usual techniques for control. For some aerodigestive cancers particularly (such as laryngeal, pharyngeal), there are independent and joint effects of tobacco and alcohol (Taylor & Rehm 2006) , so that a small percentage of these cancers may be overestimated in the current study based on those studies in the meta-analyses, which did not adequately control for these effects. Last, the procedure for adjustment of the survey data may overestimate consumption in heavy drinking categories if a key assumption for this procedure, i. e., that undercoverage is a result of missing certain heavy drinking populations such as the homeless and the institutionalized, is not valid (Gmel & Rehm 2004) . Rehm et al. (2006c) give some sensitivity analyses for potential consequences for burden of disease if certain assumptions for adjusting survey data do or do not hold true.
The fi nal point we would like to discuss concerns causality.
As outlined above, we used the usual epidemiological criteria of causality (Hill 1965; Rothman & Greenland 1998) .
In using these criteria, we stressed especially the potential biological pathways, and no disease condition was included without such a pathway. In past years, there has been doubt concerning the benefi cial effects of alcohol, especially the cardio-protective effect (Shaper 1990; Fillmore et al. 2006) . Most of these claims have been made based on epidemiological reasoning, i. e. lack of or inadequate control for confounders. While there is certainly room for improving the Int J Public Health 52 (2007) 383-392 Alcohol consumption and alcohol-attributable burden of disease © Birkhäuser Verlag, Basel, 2007 in Switzerland, 2002 quality of measurement in alcohol-epidemiological studies, particularly with respect to measurement of patterns of drinking (Rehm 1998) , these criticisms cannot address the basic question of whether there is a demonstrated biological pathway for the alcohol effect that can explain the epidemiological effects (Rehm 2007) . For the cardio-protective effect due to regular light to moderate drinking, such pathways have been demonstrated (Puddey et al. 1999; Rehm et al. 2003d) . In experimental studies, regular light to moderate alcohol consumption has been shown to increase HDL cholesterol and to have a positive effect on platelet aggregation (Rehm et al. 2003d ). In addition, other potential pathways with less conclusive evidence have been demonstrated (Puddey et al. 1999; Rehm et al. 2003d ). This was the reason why ischaemic heart disease was included in the list of alcohol-attributable disease categories. The exact quantifi cation of this effect is another matter and it may well be that the effect has been overestimated by the meta-analysis chosen (Corrao et al. 2000) because some of the underlying studies failed to control for some of the confounders. In any case, as alcohol has been identifi ed as one of the major risk factors for burden of disease on a global level (Rehm et al. 2004 ), further research is underway, which will lead to better risk-relation estimates and, in turn, to better quantifi cation of alcohol-attributable burden of disease. Despite these caveats, the estimates presented are the best possible for Switzerland for today and, for lack of better estimates, should infl uence policy. Thus, best practices to reduce per capita consumption (Babor et al. 2003; Anderson & Baumberg 2006) should apply to Switzerland, such as taxation and availability restrictions. Estos números son números netos que incorporan ya efectos cardio-protectores y otros efectos benefi ciosos del alcohol.
Conclusiones: Las limitaciones de la aproximación usada están siendo discutidas. Además, también se están tratando las cuestiones de la causalidad y la confusión.
